| Literature DB >> 30192828 |
Muhammad Rehan Sarwar1,2, Anum Saqib2, Tayyab Riaz1, Haleema Aziz1, Mosab Arafat3, Hamna Nouman1.
Abstract
BACKGROUND AND OBJECTIVES: Practice-based research (PBR) is of pivotal importance for hospital pharmacists which not only up-grades the profession but also improves the patient care. This study aimed to evaluate the attitude, perception, willingness, motivation and barriers to PBR among hospital pharmacists in Pakistan.Entities:
Mesh:
Year: 2018 PMID: 30192828 PMCID: PMC6128607 DOI: 10.1371/journal.pone.0203568
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of the participants.
| Variables | N (%) | |
|---|---|---|
| less than 25 | 67 (51.5) | |
| 25–30 | 40 (30.8) | |
| 31–35 | 12 (9.2) | |
| 36–40 | 5 (3.8) | |
| 41–45 | 4 (3.1) | |
| 46–50 | 2 (1.5) | |
| Male | 75 (57.7) | |
| Female | 55 (42.3) | |
| Pharm.D | 108 (83.1) | |
| M.Phil | 17 (13.1) | |
| PhD | 5 (3.8) | |
| < 2 | 67 (51.5) | |
| 2–5 | 42 (32.3) | |
| 6–10 | 14 (10.8) | |
| >10 | 7 (5.4) | |
| Yes | 56 (43.1) | |
| No | 74 (56.9) | |
| Yes | 22 (16.9) | |
| No | 108 (83.1) | |
| Outpatient | 32 (24.6) | |
| Inpatient | 66 (50.8) | |
| Emergency | 17 (13.1) | |
| Others | 15 (11.5) | |
| Pediatrics/neonates | 10 (7.7) | |
| ICU | 8 (6.2) | |
| Cardiac | 18 (13.8) | |
| Transplant | 7 (5.4) | |
| Nephrology | 9 (6.9) | |
| Surgery | 23 (17.7) | |
| Internal medicine | 20 (15.4) | |
| Geriatrics | 12 (9.2) | |
| Infectious diseases | 12 (9.2) | |
| Oncology | 11 (8.5) | |
| Pharmacy Administration | 14 (10.8) | |
| Basic Science (Pharmacogenomics, New structural drugs) | 15 (11.5) | |
| Pharmacoeconomics/Epidemiology | 13 (10.0) | |
| Pharmacy practice | 22 (16.9) | |
| Hospital Pharmacy | 22 (16.9) | |
| Therapeutics | 24 (18.5) | |
| Pharmacokinetics | 14 (10.8) | |
| Others | 6 (4.6) | |
* Pharm.D = Doctor of Pharmacy
† M.Phil = Masters in philosophy
‡ PhD = Doctor of philosophy
§ ICU: Intensive care unit
Attitude towards research.
| Attitude Item | Strongly disagree | Disagree | Neutral | Agree N (%) | Strongly agree N (%) | Median (IQR) |
|---|---|---|---|---|---|---|
| 1. I like to read research studies related to pharmacy practice. | 2 (1.5) | 4 (3.1) | 26 (20.0) | 73 (56.2) | 25 (19.2) | 4 (0) |
| 2. I shall be glad to be a part of research projects related to pharmacy practice. | 2 (1.5) | 6 (4.6) | 10 (7.7) | 74 (56.9) | 38 (29.2) | |
| 3. I have faith in my capabilities to apprehend research and related terminologies concerned with pharmacy practice. | 3 (2.3) | 5 (3.8) | 18 (13.8) | 68 (52.3) | 36 (27.7) | 4 (1) |
| 4. I am confident about my skills for designing research project related to pharmacy practice. | 2 (1.5) | 4 (3.1) | 31 (23.8) | 61 (46.9) | 32 (24.6) | 4 (1) |
| 5. I am self-reliant in my skill for evaluating research terms of their application to pharmacy practice. | 2 (1.5) | 5 (3.8) | 30 (23.1) | 60 (46.2) | 33 (25.4) | 4 (2) |
| 6. Pharmacy practice research is significant in recognizing and examining complications in pharmacy. | 3 (2.3) | 1 (0.8) | 9 (6.9) | 69 (53.1) | 48 (36.9) | |
| 7. Pharmacy practice research is vital in pharmacy decision-making. | 2 (1.5) | 4 (3.1) | 19 (14.6) | 57 (43.8) | 48 (36.9) | 4 (1) |
| 4 (0) | ||||||
IQR = Interquartile range
Attitude was assessed by giving 1 to Strongly disagree, 2 to Disagree, 3 to Neutral, 4 to Agree and 5 to Strongly agree.
Perceived importance of research in pharmacy practice.
| Perception Item | Strongly disagree | Disagree N (%) | Neutral | Agree | Strongly agree N (%) | Median (IQR) |
|---|---|---|---|---|---|---|
| 1. Research is of pivotal importance for a pharmacist. | - | 6 (4.6) | 28 (21.5) | 51 (39.2) | 45 (34.6) | 4 (2) |
| 2. It is crucial to be well-informed of the research fitting to the practice of pharmacy. | - | 5 (3.8) | 14 (10.8) | 70 (53.8) | 41 (31.5) | |
| 3. My routine practice relies on evidence based pharmacy practice research. | 2 (1.5) | 13 (10.0) | 34 (26.2) | 63 (48.5) | 18 (13.8) | 4 (1) |
| 4. Being a practicing pharmacist the research findings are inapt to me. | 15 (11.5) | 62 (47.7) | 26 (20.0) | 18 (13.8) | 9 (6.9) | 4 (1) |
| 5. Research is necessary to advance patient care. | 2 (1.5) | 5 (3.8) | 10 (7.7) | 58 (44.6) | 55 (42.3) | |
| 6. Research is essential for my professional recognition. | 1 (0.8) | 7 (5.4) | 27 (20.8) | 63 (48.5) | 32 (24.6) | 4 (1) |
| 7. Research is of pivotal importance for my self-assurance. | - | 9 (6.9) | 30 (23.1) | 62 (47.7) | 29 (22.3) | 4 (1) |
| 4 (0) | ||||||
IQR = Interquartile range
*Negative statement.
Perceptions were assessed by giving 1 to Strongly disagree, 2 to Disagree, 3 to Neutral, 4 to Agree and 5 to Strongly agree. For the question 4, it was assessed by giving 5 to Strongly disagree, 4 to Disagree, 3 to Neutral, 2 to Agree and 1 to Strongly agree.
Willingness to participate in research.
| Willingness Item | Strongly disagree | Disagree N (%) | Neutral | Agree | Strongly agree N (%) | Median (IQR) |
|---|---|---|---|---|---|---|
| 1. There are increased chances that I would be a part of research. | 3 (2.3) | 28 (21.5) | 50 (38.5) | 24 (18.5) | 4 (1) | |
| 2. I have the required abilities to participate in research. | 2 (1.5) | 5 (3.8) | 21 (16.2) | 78 (66.0) | 24 (18.5) | |
| 3. I would contribute in research only in case I am paid for it. | 23 (17.7) | 32 (24.6) | 39 (30.0) | 22 (16.9) | 14 (10.8) | 3 (2) |
| 4. I would need observation to participate in research. | 3 (2.3) | 7 (5.4) | 18 (13.8) | 67 (51.5) | 35 (26.9) | |
| 5.My routine activities do not allow me to indulge in research. | 2 (1.5) | 24 (18.5) | 26 (20.0) | 50 (38.5) | 28 (21.5) | 4 (1) |
| 6. I am equipped to take out time for executing research during work. | - | 23 (17.7) | 38 (29.2) | 56 (43.1) | 13 (10.0) | 4 (1) |
| 7. I shall like to take on pharmacy centered research. | 1 (0.8) | 5 (3.8) | 28 (21.5) | 71 (54.6) | 25 (19.2) | 4 (1) |
| 4 (1) | ||||||
IQR = Interquartile range
*Negative statement.
Willingness was assessed by giving 1 to Strongly disagree, 2 to Disagree, 3 to Neutral, 4 to Agree and 5 to Strongly agree. For the questions 3 and 5, it was assessed by giving 5 to Strongly disagree, 4 to Disagree, 3 to Neutral, 2 to Agree and 1 to Strongly agree.
Motivational factors to participate in research.
| Motivational Item | Strongly disagree | Disagree N (%) | Neutral | Agree | Strongly agree N (%) | Median (IQR) |
|---|---|---|---|---|---|---|
| 1. The pharmacy profession would be uplifted. | 1 (0.8) | 2 (1.5) | 6 (4.6) | 68 (52.3) | 53 (40.8) | |
| 2. Provides an opportunity to offer a chance to gain knowledge related to disease management. | - | 3 (2.3) | 8 (6.2) | 67 (51.5) | 52 (40.0) | 4 (1) |
| 3. Provide better services and increased patient care. | 1 (0.8) | 2 (1.5) | 5 (3.8) | 69 (53.1) | 53 (40.8) | |
| 4. Offer monetary reward. | 8 (6.2) | 22 (16.9) | 46 (35.4) | 39 (30.0) | 15 (11.5) | 3 (1) |
| 5. Awareness of clinical research. | - | 6 (4.6) | 28 (21.5) | 58 (44.6) | 38 (29.2) | 4 (2) |
| 6. Backing from a colleague. | 7 (5.4) | 10 (7.7) | 50 (38.5) | 48 (36.9) | 15 (11.5) | 3 (1) |
| 7. Aids me in CME (continuing medical education). | 1 (0.8) | 6 (4.6) | 34 (26.2) | 65 (50.0) | 24 (8.5) | 4 (1) |
| 8. Gives me personal gratification. | 1 (0.8) | 8 (6.2) | 28 (21.5) | 62 (47.7) | 31 (23.8) | 4 (1) |
| 9. Accessibility of replacement for my research time. | 2 (1.5) | 5 (3.8) | 55 (42.3) | 55 (42.3) | 13 (10.0) | 4 (1) |
| 10. To sustain research activities. | 3 (2.3) | 4 (3.1) | 24 (18.5) | 66 (50.8) | 33 (25.4) | 4 (1) |
| 4 (0) | ||||||
IQR = Interquartile range
Attitude was assessed by giving 1 to Strongly disagree, 2 to Disagree, 3 to Neutral, 4 to Agree and 5 to Strongly agree.
Barriers in practice-based research.
| Barriers in research | N (%) |
|---|---|
| No personal interest | 10 (7.7) |
| Not enough staff | 8 (6.2) |
| Not aware of opportunity | 9 (6.9) |
| Lack of time | 31 (23.8) |
| Never been asked to | 11 (8.5) |
| Lack of incentives | 21 (16.2) |
| Lack of knowledge | 15 (11.5) |
| Lack of support | 19 (14.6) |
| Lack of research | 6 (4.6) |
Test of statistical significance of variation in the hospital pharmacists’ attitude, perceptions, willingness, and motivation towards PBR by their characteristics.
| Variables | Attitude | Perception | Willingness | Motivation | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Negative | Positive | Poor | Good | Less | More | Low | High | ||||||
| less than 25 | 12 (9.2) | 55 (42.3) | 0.485 | 18 (13.8) | 49 (37.7) | 0.774 | 18 (13.8) | 49 (37.7) | 0.579 | 8 (6.2) | 59 (45.4) | 0.665 | |
| 25–30 | 5 (3.8) | 35 (26.9) | 7 (5.4) | 33 (25.4) | 11 (8.5) | 29 (22.3) | 6 (4.6) | 34 (26.2) | |||||
| 31–35 | 0 (0.0) | 12 (9.2) | 1 (0.8) | 11 (8.5) | 3 (2.3) | 9 (6.9) | 0 (0.0) | 12 (9.2) | |||||
| 36–40 | 1 (0.8) | 4 (3.1) | 1 (0.8) | 4 (3.1) | 2 (1.5) | 3 (2.3) | 0 (0.0) | 5 (3.8) | |||||
| 41–45 | 0 (0.0) | 4 (3.1) | 0 (0.0) | 4 (3.1) | 0 (0.0) | 4 (3.1) | 0 (0.0) | 4 (3.1) | |||||
| 46–50 | 1 (0.8) | 1 (0.8) | 1 (0.8) | 1 (0.8) | 0 (0.0) | 2 (1.5) | 0 (0.0) | 2 (1.5) | |||||
| Male | 7 (5.4) | 68 (52.3) | 9 (6.9) | 66 (50.8) | 14 (10.8) | 61 (46.9) | 3 (2.3) | 72 (55.4) | 0.072 | ||||
| Female | 12 (9.2) | 43 (33.1) | 19 (14.6) | 36 (27.7) | 20 (15.4) | 35 (26.9) | 11 (8.5) | 44 (33.8) | |||||
| Pharm. D | 16 (12.3) | 92 (70.8) | 0.183 | 24 (18.5) | 84 (64.7) | 0.634 | 29 (22.3) | 79 (60.8) | 0.271 | 11 (8.5) | 97 (74.6) | 0.176 | |
| M.Phil. | 1 (0.8) | 16 (12.3) | 3 (2.3) | 14 (10.8) | 3 (2.3) | 14 (10.8) | 3 (2.3) | 14 (10.8) | |||||
| PhD | 2 (1.5) | 3 (2.3) | 1 (0.8) | 4 (3.1) | 2 (1.5) | 3 (2.3) | 0 (0.0) | 5 (3.8) | |||||
| < 2 | 12 (9.2) | 55 (42.3) | 0.686 | 19 (14.6) | 48 (36.9) | 0.206 | 19 (14.6) | 48 (36.9) | 0.525 | 10 (7.7) | 57 (43.8) | 0.779 | |
| 2–5 | 3 (2.3) | 39 (30.0) | 6 (4.6) | 36 (27.7) | 10 (7.7) | 32 (24.6) | 4 (3.1) | 38 (29.2) | |||||
| 6–10 | 2 (1.5) | 12 (9.2) | 2 (1.5) | 12 (9.2) | 3 (2.3) | 11 (8.5) | 0 (0.0) | 14 (10.8) | |||||
| >10 | 2 (1.5) | 5 (3.8) | 1 (0.8) | 6 (4.6) | 2 (1.5) | 5 (3.8) | 0 (0.0) | 7 (5.4) | |||||
| Yes | 7 (5.4) | 49 (37.7) | 0.203 | 12 (9.2) | 44 (33.8) | 0.654 | 12 (9.2) | 44 (33.8) | 0.518 | 7 (5.4) | 49 (37.7) | 0.513 | |
| No | 12 (9.2) | 62 (47.7) | 16 (12.3) | 58 (44.6) | 22 (16.9) | 52 (40.0) | 7 (5.4) | 67 (51.5) | |||||
| Yes | 4 (3.1) | 18 (13.8) | 0.945 | 5 (3.8) | 17 (13.1) | 0.554 | 4 (3.1) | 18 (13.8) | 0.495 | 2 (1.5) | 20 (15.4) | 0.232 | |
| No | 15 (11.5) | 93 (71.5) | 2 (17.7) | 85 (65.4) | 30 (23.1) | 78 (60.0) | 12 (9.2) | 96 (73.8) | |||||
| Outpatient | 8 (6.2) | 24 (18.5) | 0.491 | 6 (4.6) | 26 (20.0) | 0.412 | 9 (6.9) | 23 (17.7) | 0.529 | 2 (1.5) | 30 (23.1) | ||
| Inpatient | 5 (3.8) | 61 (46.9) | 14 (10.8) | 52 (40.0) | 14 (10.8) | 52 (40.0) | 5 (3.8) | 61 (46.9) | |||||
| Emergency | 4 (3.1) | 13 (10.0) | 4 (3.1) | 13 (10.0) | 5 (3.8) | 12 (9.2) | 3 (2.3) | 14 (10.8) | |||||
| Others | 2 (1.5) | 13 (10.0) | 4 (3.1) | 11 (8.5) | 6 (4.6) | 9 (6.9) | 4 (3.1) | 11 (8.5) | |||||
Logistic regression analysis of factors associated with hospital pharmacists’ attitude, perceptions, willingness, and motivation towards PBR.
| Variables | Attitude | Perception | Willingness | Motivation | |
|---|---|---|---|---|---|
| OR, 95%CI, P-value | OR, 95%CI, P-value | OR, 95%CI, P-value | OR, 95%CI, P-value | ||
| Less than 25 | Ref. (1.0) | Ref. (1.0) | 0.00, 0.00, 0.99 | Ref. (1.0) | |
| 25–30 | 1.11, 0.24–4.02, 0.886 | 0.75, 0.20–2.84, 0.671 | 0.00, 0.00, 0.99 | 0.28, 0.04–2.09, 0.216 | |
| 31–35 | 0.00, 0.00, 0.998 | 1.26, 0.12–13.61, 0.852 | 0.00, 0.00, 0.99 | 0.00, 0.00, 0.99 | |
| 36–40 | 0.00, 0.00, 0.99 | 0.04, 0.00–1.71, 0.094 | 0.00, 0.00, 0.99 | 0.80, 0.00, 1.00 | |
| 41–45 | 0.00, 0.00, 0.99 | 0.00, 0.00, 0.99 | 0.15, 0.00, 1.00 | 0.00, 0.00, 0.99 | |
| 46–50 | 0.00, 0.00, 0.99 | 0.00, 0.00, 0.99 | Ref. (1.0) | 0.00, 0.00, 1.00 | |
| Male | Ref. (1.0) | Ref. (1.0) | Ref. (1.0) | 8.86, 1.15–53.74, | |
| Female | 0.44, 1.26–1.53, 0.197 | 0.16, 0.05–0.52, 0.002 | 0.40, 0.15–1.06, 0.065 | Ref. (1.0) | |
| Pharm.D | Ref. (1.0) | Ref. (1.0) | Ref. (1.0) | 0.00, 0.00, 1.00 | |
| M.Phil. | 0.00, 0.00, 0.99 | 26.00, 0.51–132.13, 0.104 | 0.00, 0.00, 0.99 | 0.00, 0.00, 1.00 | |
| PhD | 0.00, 0.00, 0.99 | 0.00, 0.00, 0.99 | 0.00, 0.00, 0.99 | Ref. (1.0) | |
| <2 | Ref. (1.0) | Ref. (1.0) | Ref. (1.0) | 0.00, 0.00, 0.99 | |
| 2–5 | 2.02, 0.46–8.84,0.350 | 1.944, 0.602–6.282, 0.266 | 0.16, 0.42–3.21, 0.78 | 0.00, 0.00, 0.99 | |
| 6–10 | 0.33, 0.04–3.03, 0.328 | 3.373, 0.307–37.048, 0.320 | 0.66, 0.12–3.52, 0.622 | 2.43, 0.00, 1.00 | |
| >10 | 0.18, 0.01–4.74, 0.307 | 2.82, 0.10–82.10, 0.547 | 0.33, 0.02–7.23, 0.485 | Ref. (1.0) | |
| Yes | Ref. (1.0) | Ref. (1.0) | Ref. (1.0) | 0.26, 0.05–1.32, 0.104 | |
| No | 0.20, 0.11–1.59, 0.442 | 1.39, 1.49–3.92, 0.537 | 0.80, 0.32–2.01, 0.634 | Ref. (1.0) | |
| Yes | Ref. (1.0) | Ref. (1.0) | Ref. (1.0) | 2.82, 0.40–19.98, 0.297 | |
| No | 0.98, 0.23–5.03, 1.084 | 0.53, 0.13–2.18, 0.376 | 0.68, 0.18–2.53, 0.566 | Ref. (1.0) | |
| Outpatient | Ref. (1.0) | Ref. (1.0) | Ref. (1.0) | 23.51, 2.04–271.53, | |
| Inpatient | 4.56, 1.07–19.42, | 0.60, 0.18–2.05, 0.417 | 1.10, 0.34–3.40, 0.863 | 12.24, 1.61–94.66, | |
| Emergency | 1.14, 0.21–6.07, 0.877 | 0.87, 0.17–4.50, 0.863 | 0.80, 0.18–3.49, 0.761 | 5.33, 0.50–57.45, 0.168 | |
| Others | 2.30, 0.32–15.50, 0.391 | 0.45, 0.08–2.47, 0.36 | 0.44, 0.10–1.90, 0.274 | Ref. (1.0) | |